Home » Topics » Science » New compound

New compound
RSS

MCC-1734 inhibits cancer cells with different resistance mechanisms

Dec. 21, 2021

DAN-311 demonstrates consistent and durable efficacy in HER2-low breast cancer models

Dec. 20, 2021

Discovery of long-acting entecavir prodrugs

Dec. 16, 2021

ASP-8731 inhibits microvascular stasis in models of sickle cell disease

Dec. 15, 2021

BCL6 PROTAC degrader ARVN-71228 shows efficacy in preclinical models of DLBCL

Dec. 15, 2021

[68Ga]SP-94 shows excellent uptake in GRP78-positive HCC tumors

Dec. 2, 2021

Discovery of the novel BCL6 BTB-specific inhibitor, AP-4-287

Nov. 29, 2021

CT-859 improves survival in a murine NASH model

Nov. 26, 2021

PCC-0105002 attenuates neuropathic pain without motor coordination-associated side effects

Nov. 25, 2021

GNE-502 shows promising efficacy in breast tumor xenograft model

Nov. 24, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 9, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...